BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Announcement by Irina Maligina and Nika Saveljeva, Daughters of Late Valerijs Maligins

  We care about the future of AS Olainfarm.

  February 2, 2018

   · 

  3 min read
• Business

  Integra LifeSciences to Host Fourth Quarter 2017 Earnings Results Conference Call on February 27, 2018

  Peter J. Arduini, president and chief executive officer, and Glenn G. Coleman, chief financial officer and corporate vice-president of International, will review fourth quarter and full year 2017 results during the call.

  February 2, 2018

   · 

  1 min read
• Business

  ARCA Biopharma Selects TransPerfect’s Trial Interactive eTMF Solution

  ARCA Biopharma today announced that ARCA biopharma has selected TransPerfect’s Trial Interactive eTMF solution as their enterprise platform for clinical trials.

  February 2, 2018

   · 

  3 min read
• Business

  Prothena to Report Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 14

  The announcement will be followed by a live audio conference call at 4:30 PM ET.

  February 2, 2018

   · 

  1 min read
• Drug Development

  Adamas Announces Publication of ADS-5102 Phase II Clinical Trial Results in Multiple Sclerosis Journal

  Placebo-controlled proof-of-concept trial demonstrated that ADS-5102 significantly improved walking speed in multiple sclerosis patients with walking impairment.

  February 2, 2018

   · 

  5 min read
• Genetown

  Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Feb. 2, 2018

  The stock options are to acquire, in the aggregate, 85,850 shares of the Company’s common stock at a per share exercise price of $15.25.

  February 2, 2018

   · 

  4 min read
• Business

  Women In Bio Announces Jane Wasman Appointed Chair of Sellas Life Sciences’ Board of Directors

  Launched in 2016, Boardroom Ready is Executive Women In Bio’s exclusive executive development platform, designed to fuel women’s participation on corporate boards in the life sciences.

  February 2, 2018

   · 

  4 min read
• 

  BioForest

  Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025

  Alder intends to use the cash to fund the development and commercialization of eptinezumab.

  February 2, 2018

   · 

  3 min read
• Business

  Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results

  Product, service and other revenue for the year ended December 31, 2017 increased by 19% to $93.5 million, compared to $78.6 million for 2016.

  February 2, 2018

   · 

  6 min read
• 

  Drug Development

  TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patients With MS

  This Phase 2 trial is a 52-week study evaluating the safety and efficacy of ublituximab at accelerated infusion times as fast as one hour.

  February 2, 2018

   · 

  6 min read